August 25, 2015
Jair C. Soares, professor and Pat R. Rutherford, Jr., chair in psychiatry, UTHealth Medical School, will present the inaugural Lynne Ora Kushel Memorial Lecture on Bipolar Disorder at the UC Davis MIND Institute on Thursday, Oct. 1.
August 24, 2015
The evaluation of new treatments for autism spectrum disorder is being hampered by the lack of validated measures to assess the progress that individuals make in such treatments. UC Davis MIND Institute researchers, in collaboration with the University of Minnesota and University of Washington, will study the utility of methods for measuring language acquisition in people with autism spectrum disorder, in order to evaluate their treatment progress, through a $125,000 seed grant from the Simons Foundation for Autism Research.
August 21, 2015
Fereydoun Hormozdiari recently has joined the UC Davis faculty as an assistant professor in the Department of Biochemistry and Molecular Medicine, affiliated with the Human Genome Center and the UC Davis MIND Institute.
August 18, 2015
Megan Y. Dennis recently joined the faculty of the UC Davis MIND Institute and the Human Genome Center as an assistant professor in biochemistry and molecular medicine. Dennis’s research involves the use of genomic and genetic techniques to explore the underlying causes of neurological disorders, including autism spectrum disorder.
July 28, 2015
UC Davis health economists have for the first time projected the total costs of caring for all people with autism spectrum disorder (ASD) in the U.S. for the current calendar year and in 10 years if effective interventions and preventive treatments for the condition are not identified and widely available.
June 24, 2015
UC Davis is stimulating innovative, collaborative brain research with a new program offering funding for projects with strong potential to lead to impactful discoveries.
June 18, 2015
Since the latter part of the 19th and early 20th centuries, intelligence tests have attempted to measure human intellectual capabilities. The most common assigns an intelligence quotient, or “IQ” score for normal intelligence in the 90-to-110 point range. Below-normal intelligence falls below 80 IQ points.
UC Davis Center for Excellence in Developmental Disabilities to hold Summer Institute on Neurodevelopmental Disorders
June 18, 2015
The 12th Annual UC Davis Summer Institute on Neurodevelopmental Disorders — one of the nation's premier gatherings of health professionals, educators and families interested in research and best practices in the field of neurodevelopmental disorders — will be held Friday, Aug. 7, from 7:30 a.m. to 5 p.m. at the UC Davis Conference Center, 550 Alumni Lane, on the University of California, Davis campus. The Institute is sponsored by the Center for Excellence in Developmental Disabilities (CEDD) of the UC Davis MIND Institute and the UC Davis Health System Office of Continuing Medical Education.
June 11, 2015
The Early Start Denver Model (ESDM), a daily play-and routines-based intervention for young children with autism that has been found to result in significant developmental gains, is offering a series of workshops in August.
June 10, 2015
The constant movement of children with attention-deficit/hyperactivity disorder (ADHD) may be distracting -- but the fidgeting also may improve their cognitive performance, a study by researchers with the UC Davis MIND Institute has found. The take-away message: The hyperactivity seen in ADHD may help children think. [en español]
June 9, 2015
An early intervention program for toddlers with autism spectrum disorder improves their intellectual abilities and reduces autism symptoms -- and those results persist years after the children originally received treatment, a new study shows.
UC Davis MIND Institute research finds differences in the brains and behavior of girls and boys with autism
May 12, 2015
New research conducted by the UC Davis MIND Institute on a large cohort of preschoolers with autism spectrum disorder has found differences in the underlying biology of their brains, and in their behavior, that may help explain how the condition affects a little-studied and poorly understood population of children: girls. [en español]
Marjorie Solomon named to Marvin 'Buzz' Oates and Family Endowed Chair in Lifespan Development in Autism
April 29, 2015
Marjorie Solomon, associate professor in the Department of Psychiatry and Behavioral Sciences, and a with a faculty member at the UC Davis MIND Institute and Imaging Research Center, has been named to the Marvin "Buzz" Oates and Family Endowed Chair in Lifespan Development in Autism in the UC Davis School of Medicine.
MIND Institute researchers receive grant to study schizophrenia in children with 22q11.2 deletion syndrome
April 21, 2015
Researchers studying a genetic disorder that in childhood causes anxiety and learning differences, but in adolescence or early adulthood results in schizophrenia in nearly one third of those affected, will investigate how emotional and intellectual challenges impact the development of early psychosis symptoms in this very high-risk population, through a new five-year, $2.5 million grant from the National Institute of Mental Health.
April 21, 2015
In a presentation scheduled for May 20 Virginia Rauh, a researcher from Columbia University, will discuss her studies of the effects of prenatal exposure to chlorpyrifos, a common insecticide and neurotoxicant, in a group of inner-city minority children.
April 2, 2015
David G. Amaral, director of research at the UC Davis MIND Institute, has been named the new editor-in-chief of Autism Research, the peer-reviewed journal of the International Society for Autism Research (INSAR) and its publishing partner, Wiley. Amaral succeeds Anthony J. Bailey, the journal’s first editor-in-chief, who will step down at the end of March after nearly six years in the position.
International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants
March 31, 2015
Simeon Boyd, UC Davis professor of genetics and pediatrics, has received a nearly $4 million, five-year grant from the National Institute of Dental and Craniofacial Research to lead a team of physicians and scientists from more than 10 centers in the United States and seven international sites, including Australia, Brazil, Bulgaria, Germany, Hungary, Italy and the United Kingdom, to study craniosynostosis, the premature fusion of the bony plates of the skull in infants.
March 26, 2015
On Monday, April 13, from 6:30 to 8:30 p.m., the UC Davis MIND Institute will partner with the Sacramento Poetry Center to present the 6th Annual Poetry & Art Night. The event will feature original works by poets who connect with the experience of living with autism. Attendees also will view the MIND Institute collection of paintings and drawings by artists with neurodevelopmental disorders.
March 26, 2015
UC Davis will establish a prestigious, leading-edge center to advance innovative research into the origins of schizophrenia: A Silvio O. Conte Center for Basic or Translational Mental-Health Research, one of only 15 such centers in the United States.
March 25, 2015
The ADHD Program at the UC Davis MIND Institute has been selected to participate in an initiative that will link people with the condition in Sacramento and beyond with clinicians, researchers, advocates, support groups and each other, through an innovative privacy-assured online platform called Platform for Engaging Everyone Responsibly, or PEER.
March 18, 2015
Randi Hagerman, medical director of the UC Davis MIND Institute, has received the prestigious International Sisley-Jerome Lejeune Award 2014 from the Paris-based Jérôme Lejeune Foundation, for her groundbreaking work developing targeted treatments for individuals with fragile X syndrome, a leading cause of intellectual disability and the leading single-gene cause of autism spectrum disorder.
March 10, 2015
Former California Senate Pro Tempore Darrell Steinberg, who recently joined UC Davis Health System as director of policy and advocacy for the UC Davis Behavioral Health Center of Excellence and visiting professor in the Department of Psychiatry and Behavioral Sciences, will present two special lectures in April.
March 9, 2015
Mani Pavuluri, founding director of the Pediatric Mood Disorders Clinic and the Pediatric Brain Research and Intervention Center at the University of Illinois, Chicago, will address brain dysfunction in pediatric bipolar disorder during the next UC Davis MIND Institute Distinguished Lecturer Series address.
March 6, 2015
How imagining technology illuminates the differences between the workings of the brain in children and adults with reading disability, or dyslexia, and those of people without the disorder, will be the topic of the March 2015 UC Davis MIND Institute Distinguished Lecturer Series presentation.
February 3, 2015
The UC Davis Center for Excellence in Developmental Disabilities (CEDD) will hold a panel discussion on “Developing and Maintaining Positive Relationships in the Community and the Family” for individuals with children with special needs on Saturday, Feb. 7, from 9 a.m. to 1 p.m. Please note: This discussion will be presented entirely in Spanish. The presentation will be held in the MIND Institute auditorium, at 2825 50th St., Sacramento. It is free and open to the public and no reservations are required. Seating is first-come, first-served. No children will be allowed.
Aubyn Stahmer, expert in translating autism research into community practice, joins UC Davis MIND Institute
January 8, 2015
Aubyn Stahmer, an expert in the translation of evidence-based autism research to community-based practice and delivery, has joined the UC Davis MIND Institute as an associate professor in the Department of Psychiatry and Behavioral Sciences.
December 17, 2014
Thomas C. Südhof, recipient of the 2013 Nobel Prize in Physiology and Medicine, will address his research on how defects in a ‘glue’ that binds together proteins at the neuronal synapses may play a role in the etiology of autism spectrum disorder, schizophrenia and other psychiatric neurodevelopmental conditions, during the first 2015 UC Davis MIND Institute Distinguished Lecturer Series address in January.
UC Davis Multidisciplinary ALS Clinic named a Certified Treatment Center of Excellence by the ALS Association
December 12, 2014
The UC Davis Multidisciplinary ALS Clinic has been named an ALS Association Certified Treatment Center of Excellence, in acknowledgement of its meeting the highest levels of established national standards of care for the management of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
December 8, 2014
Children with autism spectrum disorder (ASD) were more than twice as likely to have been exposed in utero to preeclampsia, and the likelihood of an autism diagnosis was even greater if the mother experienced more severe disease, a large study by researchers with the UC Davis MIND Institute has found.
December 4, 2014
The UC Davis MIND Institute on Wednesday celebrated the achievements of Medical Director Randi Hagerman, who in October received the C. Anderson Aldrich Award from the American Academy of Pediatrics, one of the most prestigious awards in the United States for a pediatrician.
December 3, 2014
Hundreds of participants in UC Davis MIND Institute research and their families will head into the woods to “Explore the Great Outdoors” during its 12th Annual Thank You Party on Saturday, Dec. 6, from 1 to 4 p.m. The party is held to thank the children, adolescents, adults and their families who make the MIND Institute's groundbreaking research into autism and other neurodevelopmental conditions possible.
December 1, 2014
Natacha Akshoomoff, UC San Diego associate professor of psychiatry, will discuss “How the diagnosis of autism helps us learn more about autism,” during the December UC Davis MIND Institute Distinguished Lecturer series presentation.
November 26, 2014
Beginning in February, the UC Davis MIND Institute will offer the Adult Social Knowledge (ASK) Workshop for individuals 18 to 35 with a diagnosis of an autism spectrum disorder, such as high-functioning autism or Asperger syndrome. The workshop’s aims are to provide adults with autism an opportunity to practice their social skills in a relaxed and comfortable atmosphere while having fun.
November 12, 2014
In its first clinical application in pediatric patients, an investigational medication developed and manufactured at UC Davis has been found to effectively treat children with life-threatening and difficult-to-control epileptic seizures without side effects, according to a research report by scientists at UC Davis and Northwestern University.
UC Davis MIND Institute researchers to establish new tests to evaluate cognitive growth in people with intellectual disability
October 30, 2014
Researchers with the UC Davis MIND Institute will develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess accurately: those with an intellectual disability, formerly termed mental retardation. The research will be funded through a new, five-year, $3.2 million grant from the National Institutes of Health (NIH).
October 27, 2014
Kay Redfield Jamison, Dalio Family Professor in Mood Disorders and co-director of the Mood Disorders Center at the Johns Hopkins School of Medicine, will discuss "Professional and Personal Perspectives on Bipolar Illness," during a lecture on Thursday, Nov. 6, at 5 p.m. in the auditorium of the UC Davis MIND Institute, 2825 50th St.
Young Adult Outcomes topic of next UC Davis MIND Institute Distinguished Lecturer Series presentation
October 17, 2014
Research examining what happens to young adults with autism spectrum disorder when they leave high school will be the topic of the November UC Davis MIND Institute Distinguished Lecturer Series presentation. The discussion, on “Young Adult Outcomes,” will be held from 4:30 to 6 p.m. at the MIND Institute, 2825 50th St., Sacramento.
October 15, 2014
Randi Jenssen Hagerman, medical director of the UC Davis MIND Institute, Distinguished Professor of Pediatrics and Endowed Chair in Fragile X Research and Treatment, has received the prestigious C. Anderson Aldrich Award in Child Development for her outstanding contributions in the field of child development from the American Academy of Pediatrics, the professional organization for pediatricians in the United States.
MIND Institute receives $900,000 grant to study use of sertraline in young children with autism spectrum disorder
October 8, 2014
Focusing on treatments to ameliorate autism symptoms, researchers with the UC Davis MIND Institute will launch the first study to examine the effectiveness of the use of sertraline, commonly known as Zoloft®™, in children as young as 2 to 6 years, through a three-year, $900,000 grant from the U.S. Health Resources and Services Administration (HRSA).
October 6, 2014
How alterations in a single gene on the X chromosome affects neurological and psychological functioning in men as they age is the subject of a new study by UC Davis MIND Institute researchers.
MIND Institute slates seminar to address stress among families caring for people with neurodevelopmental disorders
October 6, 2014
The UC Davis MIND Institute’s venerable Minds Behind the MIND series will launch its 2014-15 season in October with a departure from its previous format. The quarterly evening lectures have been replaced by Saturday morning presentations featuring UC Davis faculty and community representatives.
September 21, 2014
Mothers of children with autism are significantly less likely to report taking iron supplements before and during their pregnancies than the mothers of children who are developing normally, a study by researchers with the UC Davis MIND Institute has found.
September 15, 2014
Katherine Rauen, professor in the Department of Pediatrics and a physician-scientist affiliated with UC Davis MIND Institute and UC Davis Children’s Hospital, has received the 2014 Rare Champion of Hope Honoree in Science.
September 8, 2014
Treatment at the earliest age when signs of autism spectrum disorder (ASD) appear – sometimes in infants as young as 6 months old – significantly reduces symptoms so that, by age 3, most who received the therapy had neither ASD nor developmental delay, a UC Davis MIND Institute research study has found. [español]